Risk factors associated with the occurrence of breast cancer after bilateral salpingo-oophorectomy in high-risk women

Cancer Epidemiology
Teresa Ramon Y CajalAgusti Barnadas

Abstract

Bilateral salpingo-oophorectomy (BSO) is a common procedure for preventing breast and ovarian cancer in high-risk women. The goal of this study was to determine the incidence of subsequent breast cancer (BC) in a high-risk population and to identify clinical and epidemiological predictors of BC following BSO. One hundred and thirty-three consecutive high-risk women, tested for BRCA1 and BRCA2 mutations due to family history, underwent preventive or therapeutic BSO at one of the study hospitals. One hundred and three patients had breast tissue at risk and were considered evaluable for the event-free survival analysis. Twenty-five women harbored a deleterious mutation in BRCA1 and 25 in BRCA2 genes. Fifteen cases of invasive BC were diagnosed with a median interval of 49 months after BSO. Multivariate analysis showed that a prior BC after 50 years of age (p=0.004), age over 50 years at the time of BSO (p=0.005), and prior replacement or contraceptive hormonal treatment (p=0.007) were significantly associated with a shorter event-free survival. In conclusion, age at prior diagnosis of cancer, age at BSO and prior hormonal treatment may be predictors of breast cancer after BSO.

References

Jan 17, 1997·International Journal of Cancer. Journal International Du Cancer·C SchairerL A Brinton
May 25, 2002·The New England Journal of Medicine·Noah D KauffKenneth Offit
May 25, 2002·The New England Journal of Medicine·Timothy R RebbeckUNKNOWN Prevention and Observation of Surgical End Points Study Group
Dec 5, 2002·Journal of the National Cancer Institute·Steven A NarodJean-Sebastien Brunet
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kelly MetcalfeSteven A Narod
Mar 1, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Roger L MilneAlice S Whittemore
Oct 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy R RebbeckUNKNOWN PROSE Study Group
Oct 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea EisenSteven A Narod
Nov 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joan L KramerMark H Greene
Feb 13, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Noah D KauffTimothy R Rebbeck
May 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roger L MilneJavier Benítez
Sep 25, 2008·Journal of the National Cancer Institute·Rowan T Chlebowski, Ross L Prentice
Sep 25, 2008·Journal of the National Cancer Institute·Andrea EisenUNKNOWN Hereditary Breast Cancer Clinical Study Group
Jan 15, 2009·Journal of the National Cancer Institute·Timothy R RebbeckSusan M Domchek
Apr 16, 2009·European Journal of Human Genetics : EJHG·D Gareth R EvansFiona Lalloo

❮ Previous
Next ❯

Citations

Mar 29, 2019·Hereditary Cancer in Clinical Practice·Janusz MenkiszakJacek Gronwald

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.